Life-Changing Gene Therapy for Beta-Thalassemia Patients with Jennifer Schneiderman, MD

from Breakthroughs · host Northwestern University

A novel gene therapy promoted transfusion independence in more than 90 percent of adult and pediatric patients with transfusion-dependent beta-thalassemia. Study co-author Jennifer Schneiderman, MD, discusses results, published in the New England Journal of Medicine.

Episode metadata supplied by the publisher feed · Published Apr 25, 2022

Embed this episode

Attribution link and audio player

NOW PLAYING

Life-Changing Gene Therapy for Beta-Thalassemia Patients with Jennifer Schneiderman, MD

0:00 19:49

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Breakthroughs?

This episode is 19 minutes long.

When was this Breakthroughs episode published?

This episode was published on April 25, 2022.

Can I download this Breakthroughs episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!